查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654282

研究蛋白质市场规模、份额、趋势分析报告：按产品、宿主细胞、最终用途、地区和细分市场预测，2025 年至 2030 年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product, By Host Cell, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

研究蛋白质市场的成长和趋势

根据 Grand View Research, Inc. 的新报告，全球研究蛋白质市场规模预计到 2030 年将达到 17.5 亿美元。

预计 2025 年至 2030 年间，市场复合年增长率为 11.49%。预计肿瘤学领域研发投入的增加和个人化药物需求的增加将促进市场的成长。此外，许多国家政府对各种临床研究的投资增加也有望推动市场成长。此外，新兴国家生物技术产业的不断进步将进一步推动预测期内的市场成长。

由于疫苗、诊断和治疗开发研究活动的激增，COVID-19 大流行对市场产生了积极影响。随着监管机构致力于加快候选疫苗的核准流程，对契约製造的需求增加。儘管 mRNA 疫苗等新型疫苗平台已引起广泛关注，但几种重组蛋白疫苗的替代品也正在接受评估。例如，2022 年 7 月，Novavax, Inc. 的新冠疫苗 (NVX-CoV2373) 获得了在欧盟使用的扩大有条件上市核准。此外，此次疫情凸显了生技药品对敏捷和灵活製造能力的需求。预计这一因素将在不久的将来增强竞争格局并推动市场成长。

根据全球基因统计，截至2019年10月，全球有超过4亿人患有罕见疾病或遗传疾病。这些数字表明迫切需要改善治疗、临床环境和健康意识。对于药物开发来说，对药物标靶机制的先进研究和知识至关重要。许多地区正在透过队列计划建立生物库，为研究人员提供高品质样本，以彻底改变治疗工作。因此，预计人们将更加关注发现各种疾病的生物标记。因此，预计研究力度的加大和政府对建设更好的医疗保健基础设施的兴趣将增强研究蛋白质的应用，从而推动市场成长。

然而，蛋白质生产是一个耗时的过程，通常需要高维护的工作条件。儘管对这些重组产品的需求很高且不断增长，但监管机构的支持仍然进展缓慢。用于研究的蛋白质通常透过宿主或表现系统产生，其中透过转染、细菌转化或病毒转导步骤来表达特异性于感兴趣产品的基因。这个复杂的过程常常受到非目标区域的过度表现的影响，而且很耗时。因此，缺乏关于重组技术的具体指导方针和法规，成为研究蛋白质市场蓬勃发展的一大障碍。

研究级蛋白质市场报告重点

  • 按产品划分，细胞激素和生长因子部分将在 2024 年占据市场主导地位，收益占有率最大，为 23.61%，预计在预测期内复合年增长率最快，为 17.62%。这是因为它在药物发现和开发的各种临床试验中发挥作用。
  • 按宿主细胞划分，哺乳动物细胞部分在 2024 年占据市场主导地位，收益占有率最大，为 55.73%。其巨大份额主要是因为它们的生物结构与人类细胞相似，有助于生产单株抗体和疫苗等生物製药。
  • 根据最终用途，製药和生物技术公司占最大份额，到 2024 年将达到 61.48%。由于药物发现和开发的研究活动增加以及个人化药物的需求不断增加，预计预测期内对研究蛋白质的需求将会增加。
  • 按地区划分，北美将占据市场主导地位，到 2024 年其收入份额将达到 44.47%。这一巨大份额归功于主要市场参与企业的存在和强大的医疗保健基础设施。预计这些因素将在预测期内推动该地区的研究蛋白质市场的发展。

目录

第 1 章研究蛋白质市场：调查方法与范围

第 2 章。

  • 市场展望
  • 段简介
  • 竞争格局概况

3. 研究蛋白质市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • PESTEL 分析
    • 波特五力分析
    • COVID-19影响分析

第四章 产品业务分析

  • 产品细分仪表板
  • 研究蛋白质市场：产品变异分析
  • 2018 年至 2030 年全球研究级蛋白质市场规模及趋势分析（依产品划分）
  • 细胞激素和生长因子
    • 细胞激素和生长因子市场，2018-2030
    • 干扰素（IFN）
    • 白细胞介素(IL)
    • 其他的
  • 抗体
    • 抗体，2018-2030
  • 免疫查核点蛋白
    • 免疫查核点蛋白市场，2018-2030
  • 病毒抗原
    • 病毒抗原市场，2018-2030
  • 酵素
    • 酵素市场，2018-2030
    • 激酶
    • 代谢酵素
    • 其他的
  • 重组调节蛋白
    • 重组调节蛋白市场，2018 - 2030 年
  • 荷尔蒙
    • 荷尔蒙市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

5. 宿主细胞业务分析

  • 宿主细胞细分仪表板
  • 研究蛋白质市场：宿主细胞变异分析
  • 2018 年至 2030 年全球研究蛋白质市场规模及趋势分析（按宿主细胞）
  • 哺乳动物细胞
    • 哺乳动物细胞市场，2018-2030
  • 细菌细胞
    • 细菌细胞市场，2018-2030
  • 酵母和真菌
    • 酵母和真菌市场，2018-2030
  • 昆虫细胞
    • 昆虫细胞市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第六章 最终用途业务分析

  • 最终用途细分仪表板
  • 研究蛋白质市场：最终用途变异分析
  • 2018 年至 2030 年全球研究级蛋白质市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
    • 2018-2030 年製药与生技市场
  • 学术研究所
    • 学术研究市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章 区域经营分析

  • 区域控制面板
  • 2018-2030 年市场规模、预测及趋势分析
  • 北美洲
    • 2018 至 2030 年北美研究蛋白质市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018 至 2030 年欧洲研究蛋白质市场
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区研究蛋白质市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲研究蛋白质市场，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东和非洲研究蛋白质市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
  • 战略地图
  • Company Position Analysis, 2024
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • Miltenyi BIoTec
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • ACROBiosystems
    • Sino Biological, Inc.
    • ProSpec-Tany TechnoGene Ltd.
    • New England Biolabs
Product Code: GVR-4-68040-130-6

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is anticipated to reach USD 1.75 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.49% from 2025 to 2030. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.61% in 2024 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2024. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.48% in 2024. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.47% in 2024. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. End Use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Research-grade Proteins Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing use of recombinant proteins in research activities
      • 3.3.1.2. Growing research activities for drug discovery and precision medicine
      • 3.3.1.3. Rising adoption of biologics & biosimilars
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Regulatory and safety concerns regarding protein production
      • 3.3.2.2. Dearth of skilled personnel and expertise
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTEL Analysis
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Research-grade Proteins Market: Product Movement Analysis
  • 4.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cytokines & Growth Factors
    • 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.4.2. Interferons (IFNs)
      • 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.4.3. Interleukins (ILs)
      • 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Antibodies
    • 4.5.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.6. Immune Checkpoint Proteins
    • 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.7. Virus Antigens
    • 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.8. Enzymes
    • 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.2. Kinases
      • 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.8.3. Metabolic Enzymes
      • 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.9. Recombinant Regulatory Proteins
    • 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.10. Hormones
    • 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Host Cell Segment Dashboard
  • 5.2. Research-grade Proteins Market: Host Cell Movement Analysis
  • 5.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
  • 5.4. Mammalian Cells
    • 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.5. Bacterial Cells
    • 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Yeast & Fungi
    • 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.7. Insect Cells
    • 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Research-grade Proteins Market: End Use Movement Analysis
  • 6.3. Global Research-Grade Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.4. Spain
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.5. France
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.6. Italy
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Abcam Plc
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Miltenyi Biotec
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Product Benchmarking
      • 8.4.3.3. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Techne
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Proteintech Group, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. ACROBiosystems
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Sino Biological, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. ProSpec-Tany TechnoGene Ltd.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 6 North America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 9 U.S research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 12 Canada research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 15 Mexico research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 19 Europe research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 20 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 22 UK research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 25 Germany research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 26 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 27 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 28 France research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 31 Italy research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 34 Spain research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 37 Denmark research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 40 Sweden research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 43 Norway research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 49 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 50 China research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 53 Japan research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 54 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 55 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 56 India research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 57 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 59 South Korea research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 62 Australia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 65 Thailand research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 69 Latin America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 72 Brazil research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 75 Argentina research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 82 South Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 88 UAE research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 91 Kuwait research-grade proteins market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global research-grade proteins market- Key market driver analysis
  • Fig. 7 Global research-grade proteins market - Key market restraint analysis
  • Fig. 8 Global research-grade proteins market - Porter's analysis
  • Fig. 9 Global research-grade proteins market - PESTEL analysis
  • Fig. 10 Global research-grade proteins market: Product outlook key takeaways
  • Fig. 11 Global research-grade proteins market: Product movement analysis
  • Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
  • Fig. 27 Global research-grade proteins market: Host cells movement analysis
  • Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global research-grade proteins market: End use outlook key takeaways
  • Fig. 34 Global research-grade proteins market: End use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global research-grade proteins market: Regional movement analysis
  • Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 45 UK research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 47 France research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 55 China research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 56 India research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 68 Strategy framework